Cannabidiol Safety In Question At US FDA? Exploding Market Suggests Not So Much

A report FDA submitted to Congress earlier in March on determining an enforcement discretion policy for CBD-containing non-drug products did little to indicate it is approaching a decision. It's likely that FDA officials are reasonably confident of CBD's safety in food and supplements because the agency has allowed the market to proliferate.

US map-cannibis-plants

More from Regulation

More from Policy & Regulation